Depressive (Depression) Disorder Market

Depression is a disorder of the brain affecting the ability to think, feel, and handle situations like sleeping, eating, or working. It is a mood disorder characterized by persistently low mood in which there is a feeling of sadness & loss of interest.

Depression also called clinical depression, dysthymic disorder, major depressive disorder & unipolar depression. It is of various types like major depressive disorder (MDD), perinatal depression, psychotic depression, seasonal depression and bipolar depression.

Types of Depression in medical terms are as below:

1. Major depression
2. Clinical depression
3. Major depressive disorder
4. Persistent depressive disorder
5. Dysthymia
6. Dysphoric disorder.

Symptoms of Depression:

• Loss of interest in favorite activities
• Overeating, or not wanting to eat at all
• Feeling sad or “empty”
• Not being able to sleep, or sleeping too much
• Feeling very tired
• Feeling hopeless, irritable, anxious, or guilty
• Aches or pains, headaches, cramps, or digestive problems
• Thoughts of death or suicide

The global depressive disorder market is expected to grow and overcome falling revenues due to patent expiry with better innovative drugs and therapies. The US has highest depression disorder prevalence along with highest prevalence of bipolar depression & schizophrenia. With growing awareness and better access to medical facilities, the depressive disorder market is expected to grow worldwide, especially in Asia-Pacific region.

The report offers an in-depth analysis of the “Global Depressive Disorder Market” segmented into global and regional markets. Competition is concentrated in the hands of few major pharmaceutical companies out of which Pfizer Inc., AstraZeneca, Eli Lilly and company, and Lundbeck have been covered in the report.

For More Information About Depressive Disorder Market Report Visit @ http://www.marketreportsonline.com/496438.html.